Abstract |
Neurohormonal changes in congestive heart failure (CHF) include an enhanced peripheral sympathetic nerve activity which results in increased release of noradrenaline, neuropeptide Y and ATP. To examine if such changes in CHF would modulate peripheral pre- and postsynaptic receptors of ATP and its degradation product adenosine, experiments were performed in a rat model of ischaemic CHF. In this model, ischaemia was induced in rats by ligation of the left coronary artery. Our results demonstrate that there is a selective downregulation of P2X receptor-mediated pressor effects, while the hypotensive effects mediated by the endothelial P2Y receptors are unaffected in CHF. Moreover, the adenosine-mediated inhibitory effects on heart rate and blood pressure were also attenuated in the CHF rats. The most important changes in adenosine and P2-receptor function induced by ischaemic CHF were the reduced pressor effect mediated by the P2X receptor and the increased heart rate due to an attenuated inhibitory effect of adenosine.
|
Authors | X H Zhao, X Y Sun, D Erlinge, L Edvinsson, T Hedner |
Journal | Blood pressure
(Blood Press)
Vol. 9
Issue 2-3
Pg. 152-61
( 2000)
ISSN: 0803-7051 [Print] England |
PMID | 10855740
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Purinergic P2 Receptor Agonists
- Receptors, Purinergic P2
- Adenosine Triphosphate
- Adenosine
|
Topics |
- Adenosine
(pharmacology, physiology)
- Adenosine Triphosphate
(pharmacology)
- Animals
- Blood Pressure
(drug effects)
- Cardiovascular System
(physiopathology)
- Decerebrate State
(physiopathology)
- Down-Regulation
- Electric Stimulation
- Ganglia
(physiopathology)
- Heart Failure
(complications, physiopathology)
- Heart Rate
(drug effects)
- Male
- Myocardial Infarction
(etiology, pathology)
- Purinergic P2 Receptor Agonists
- Rats
- Rats, Sprague-Dawley
- Receptors, Purinergic P2
(physiology)
|